{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T08:24:11Z","timestamp":1788942251446,"version":"build-2803163510"},"reference-count":138,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Reproductive Immunology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jri.2024.104282","type":"journal-article","created":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T23:18:47Z","timestamp":1718666327000},"page":"104282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Immunological mechanisms in preeclampsia: A narrative review"],"prefix":"10.1016","volume":"164","author":[{"given":"Farid","family":"Javandoust Gharehbagh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Sadegh","family":"Soltani-Zangbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousef","family":"Yousefzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jri.2024.104282_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejogrb.2013.05.005","article-title":"Global and regional estimates of preeclampsia and eclampsia: a systematic review","volume":"170","author":"Abalos","year":"2013","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"5","key":"10.1016\/j.jri.2024.104282_bib2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.thromres.2009.07.011","article-title":"Mechanisms of antiphospholipid antibody-associated pregnancy complications","volume":"124","author":"Abrahams","year":"2009","journal-title":"Thromb. Res."},{"key":"10.1016\/j.jri.2024.104282_bib3","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/HYPERTENSIONAHA.119.13360","article-title":"Predictive performance of plgf (placental growth factor) for screening preeclampsia in asymptomatic women: a systematic review and meta-analysis","volume":"74","author":"Agrawal","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.jri.2024.104282_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.884275","article-title":"Human leukocyte antigens in pregnancy and preeclampsia","volume":"13","author":"Aisagbonhi","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.jri.2024.104282_bib5","unstructured":"Al-Timimi, F.A., et al., The role of interferon-g gene polymorphism in spontaneous abortion."},{"key":"10.1016\/j.jri.2024.104282_bib6","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.3389\/fimmu.2020.01864","article-title":"Mechanisms of key innate immune cells in early- and late-onset preeclampsia","volume":"11","author":"Aneman","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.jri.2024.104282_bib7","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0008-6363(02)00844-1","article-title":"Microvascular permeability is related to circulating levels of tumour necrosis factor-alpha in pre-eclampsia","volume":"58","author":"Anim-Nyame","year":"2003","journal-title":"Cardiovasc Res."},{"key":"10.1016\/j.jri.2024.104282_bib8","unstructured":"Anvari, F., , 2015. Anvari, F., et al., 2015. Investigating the association of il-17a and il-17f with susceptibility to pre-eclampsia in iranian women.."},{"key":"10.1016\/j.jri.2024.104282_bib9","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1084\/jem.192.2.259","article-title":"Interferon gamma contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy","volume":"192","author":"Ashkar","year":"2000","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.jri.2024.104282_bib10","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0143-4004(98)91039-6","article-title":"Role of placenta growth factor (pigf) in human extravillous trophoblast proliferation, migration and invasiveness","volume":"19","author":"Athanassiades","year":"1998","journal-title":"Placenta"},{"key":"10.1016\/j.jri.2024.104282_bib11","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/bmj.39335.385301.BE","article-title":"Pre-eclampsia and risk of cardiovascular disease and cancer in later life: Systematic review and meta-analysis","volume":"335","author":"Bellamy","year":"2007","journal-title":"Bmj"},{"key":"10.1016\/j.jri.2024.104282_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1144170","article-title":"Preeclampsia pathophysiology and adverse outcomes during pregnancy and postpartum","volume":"10","author":"Bisson","year":"2023","journal-title":"Front. Med."},{"key":"10.1016\/j.jri.2024.104282_bib13","first-page":"724","article-title":"Endothelial dysfunction in preeclampsia and eclampsia: Current etiology and future non-invasive assessment","volume":"5","author":"Blum","year":"2003","journal-title":"Isr. Med Assoc. J."},{"key":"10.1016\/j.jri.2024.104282_bib14","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jri.2007.03.006","article-title":"Preeclampsia: a view through the danger model","volume":"76","author":"Bonney","year":"2007","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2024.104282_bib15","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1016\/j.molimm.2007.12.025","article-title":"Decidual endothelial cells express surface-bound c1q as a molecular bridge between endovascular trophoblast and decidual endothelium","volume":"45","author":"Bulla","year":"2008","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jri.2024.104282_bib16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jri.2009.06.124","article-title":"Complement production by trophoblast cells at the feto-maternal interface","volume":"82","author":"Bulla","year":"2009","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2024.104282_bib17","article-title":"Pre-eclampsia: Pathophysiology and clinical implications","volume":"366","author":"Burton","year":"2019","journal-title":"Bmj"},{"key":"10.1016\/j.jri.2024.104282_bib18","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1161\/HYPERTENSIONAHA.112.194324","article-title":"Preeclampsia is characterized by placental complement dysregulation","volume":"60","author":"Buurma","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.jri.2024.104282_bib19","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3389\/fimmu.2014.00253","article-title":"Regulation of the anti-inflammatory cytokines interleukin-4 and interleukin-10 during pregnancy","volume":"5","author":"Chatterjee","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jri.2024.104282_bib20","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/jhh.2017.61","article-title":"Placental growth factor and pre-eclampsia","volume":"31","author":"Chau","year":"2017","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.jri.2024.104282_bib21","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.3390\/ijms25084532","article-title":"The pathophysiological, genetic, and hormonal changes in preeclampsia: a systematic review of the molecular mechanisms","volume":"25","author":"Chiang","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jri.2024.104282_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11906-018-0833-7","article-title":"The role of interleukin-10 in the pathophysiology of preeclampsia","volume":"20","author":"Cubro","year":"2018","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.jri.2024.104282_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3858\/emm.2012.44.1.025","article-title":"The discovery of placenta growth factor and its biological activity","volume":"44","author":"De Falco","year":"2012","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jri.2024.104282_bib24","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.autrev.2004.07.002","article-title":"Activating auto-antibodies against the at1 receptor in preeclampsia","volume":"4","author":"Dechend","year":"2005","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jri.2024.104282_bib25","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0002-9378(98)70160-7","article-title":"Etiology and pathogenesis of preeclampsia: current concepts","volume":"179","author":"Dekker","year":"1998","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jri.2024.104282_bib26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/aji.12000","article-title":"Complement in pregnancy: A delicate balance","volume":"69","author":"Denny","year":"2013","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2024.104282_bib27","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/21691401.2018.1491480","article-title":"A study of the association between the sflt-1\/pigf ratio and preeclampsia in xinjiang uygur autonomous region of china","volume":"46","author":"Ding","year":"2018","journal-title":"Artif. Cells, Nanomed., Biotechnol."},{"key":"10.1016\/j.jri.2024.104282_bib28","doi-asserted-by":"crossref","first-page":"8519","DOI":"10.4049\/jimmunol.179.12.8519","article-title":"Nlrp2, an inhibitor of the nf-\u03bab pathway, is transcriptionally activated by nf-\u03bab and exhibits a nonfunctional allelic variant","volume":"179","author":"Fontalba","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jri.2024.104282_bib29","first-page":"61","article-title":"Hla-e, hla-f and hla-g\u2014the non-classical side of the mhc cluster","volume":"3","author":"Foroni","year":"2014","journal-title":"HLA Assoc. Important Dis."},{"key":"10.1016\/j.jri.2024.104282_bib30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1677\/JOE-10-0027","article-title":"Role of extracellular signal-regulated kinase and akt cascades in regulating hypoxia-induced angiogenic factors produced by a trophoblast-derived cell line","volume":"206","author":"Fujita","year":"2010","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.jri.2024.104282_bib31","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/ncpneph0623","article-title":"Hypertension in pregnancy: An emerging risk factor for cardiovascular disease","volume":"3","author":"Garovic","year":"2007","journal-title":"Nat. Clin. Pract. Nephrol."},{"key":"10.1016\/j.jri.2024.104282_bib32","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.4049\/jimmunol.178.9.5949","article-title":"Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles","volume":"178","author":"Germain","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jri.2024.104282_bib33","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1084\/jem.20061022","article-title":"Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction","volume":"203","author":"Girardi","year":"2006","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.jri.2024.104282_bib34","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.3389\/fimmu.2020.01681","article-title":"Essential role of complement in pregnancy: From implantation to parturition and beyond","volume":"11","author":"Girardi","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.jri.2024.104282_bib35","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2147\/IJWH.S321128","article-title":"Treatment outcomes and determinants of eclampsia and severe preeclampsia among pregnant women admitted to selected tertiary hospitals in ethiopia: a cohort study","author":"Godana","year":"2021","journal-title":"Int. J. Women'S. Health"},{"key":"10.1016\/j.jri.2024.104282_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.717832","article-title":"Key gene and functional pathways identified in unexplained recurrent spontaneous abortion using targeted rna sequencing and clinical analysis","volume":"12","author":"Gu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jri.2024.104282_bib37","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.3390\/jcm9072245","article-title":"Preeclampsia is a syndrome with a cascade of pathophysiologic events","volume":"9","author":"Gyselaers","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jri.2024.104282_bib38","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1159\/000484378","article-title":"Preimplantation factor (pif) promotes hla-g, -e, -f, -c expression in jeg-3 choriocarcinoma cells and endogenous progesterone activity","volume":"43","author":"Hakam","year":"2017","journal-title":"Cell Physiol. Biochem"},{"key":"10.1016\/j.jri.2024.104282_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2019.01236","article-title":"Syncytiotrophoblast-derived extracellular vesicles in pathophysiology of preeclampsia","volume":"10","author":"Han","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.jri.2024.104282_bib40","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.3389\/fphys.2019.01236","article-title":"Syncytiotrophoblast-derived extracellular vesicles in pathophysiology of preeclampsia","volume":"10","author":"Han","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.jri.2024.104282_bib41","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1600-0897.1996.tb00185.x","article-title":"Altered expression of human leukocyte antigen g (hla-g) on extravillous trophoblasts in preeclampsia: Immunohistological demonstration with anti-hla-g specific antibody \"87g\" and anti-cytokeratin antibody \"cam5.2","volume":"36","author":"Hara","year":"1996","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2024.104282_bib42","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1161\/HYPERTENSIONAHA.108.124115","article-title":"Prevalence of agonistic autoantibodies against the angiotensin ii type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study","volume":"53","author":"Herse","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.jri.2024.104282_bib43","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1084\/jem.20041214","article-title":"Combinations of maternal kir and fetal hla-c genes influence the risk of preeclampsia and reproductive success","volume":"200","author":"Hiby","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jri.2024.104282_bib44","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s13730-018-0373-7","article-title":"Clinical usefulness of serum levels of soluble fms-like tyrosine kinase 1\/placental growth factor ratio to rule out preeclampsia in women with new-onset lupus nephritis during pregnancy","volume":"8","author":"Hirashima","year":"2019","journal-title":"CEN Case Rep."},{"key":"10.1016\/j.jri.2024.104282_bib45","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s13730-018-0373-7","article-title":"Clinical usefulness of serum levels of soluble fms-like tyrosine kinase 1\/placental growth factor ratio to rule out preeclampsia in women with new-onset lupus nephritis during pregnancy","volume":"8","author":"Hirashima","year":"2019","journal-title":"CEN Case Rep."},{"key":"10.1016\/j.jri.2024.104282_bib46","doi-asserted-by":"crossref","first-page":"17976","DOI":"10.1074\/jbc.M113.451831","article-title":"Proteolytic processing regulates placental growth factor activities","volume":"288","author":"Hoffmann","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jri.2024.104282_bib47","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.bpobgyn.2011.01.006","article-title":"Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy","volume":"25","author":"Hutcheon","year":"2011","journal-title":"Best. Pr. Res Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.jri.2024.104282_bib48","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.placenta.2008.06.011","article-title":"The functional role of the renin-angiotensin system in pregnancy and preeclampsia","volume":"29","author":"Irani","year":"2008","journal-title":"Placenta"},{"key":"10.1016\/j.jri.2024.104282_bib49","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.jacc.2020.08.014","article-title":"Preeclampsia\u2014pathophysiology and clinical presentations: Jacc state-of-the-art review","volume":"76","author":"Ives","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jri.2024.104282_bib50","first-page":"94","article-title":"Quantified colocalization reveals heterotypic histocompatibility class i antigen associations on trophoblast cell membranes","volume":"89","author":"Jabeen","year":"2013","journal-title":"Relev. Hum. Pregnancy Biol. Reprod.."},{"key":"10.1016\/j.jri.2024.104282_bib51","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1080\/08820139.2021.1904976","article-title":"Tigit and cd155 as immune-modulator receptor and ligand on cd4+ t cells in preeclampsia patients","volume":"51","author":"Kamrani","year":"2022","journal-title":"Immunol. Investig."},{"key":"10.1016\/j.jri.2024.104282_bib52","doi-asserted-by":"crossref","first-page":"6744","DOI":"10.3390\/ijms24076744","article-title":"Literature review: The sflt1\/plgf ratio and pregestational maternal comorbidities: New risk factors to predict pre-eclampsia","volume":"24","author":"Karpova","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jri.2024.104282_bib53","doi-asserted-by":"crossref","first-page":"45","DOI":"10.11591\/ijphs.v8i1.16646","article-title":"Age, parity and birth spacing to the incidence of preeclampsia","volume":"8","author":"Kartikadewi","year":"2019","journal-title":"Int. J. Public Health Sci. (IJPHS)"},{"key":"10.1016\/j.jri.2024.104282_bib54","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1210\/en.2004-1028","article-title":"Hypoxia and sflt-1 in preeclampsia: The \u201cchicken-and-egg\u201d question","volume":"145","author":"Karumanchi","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.jri.2024.104282_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1095\/biolreprod.102.014977","article-title":"Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia","volume":"69","author":"Kaufmann","year":"2003","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.jri.2024.104282_bib56","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/pd.3995","article-title":"Can detection of late-onset pe at triage by sflt-1 or plgf be improved by the use of additional biomarkers?","volume":"32","author":"Kaufmann","year":"2012","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.jri.2024.104282_bib57","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/pd.3995","article-title":"Can detection of late-onset pe at triage by sflt-1 or plgf be improved by the use of additional biomarkers?","volume":"32","author":"Kaufmann","year":"2012","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.jri.2024.104282_bib58","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.4049\/jimmunol.1601279","article-title":"Activating kir2ds4 is expressed by uterine nk cells and contributes to successful pregnancy","volume":"197","author":"Kennedy","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.jri.2024.104282_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00625","article-title":"Memory t cells in pregnancy","volume":"10","author":"Kieffer","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jri.2024.104282_bib60","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1186\/s12884-022-04817-6","article-title":"The prognostic utility of soluble fms-like tyrosine kinase-1 (sflt-1) and placental growth factor (pigf) biomarkers for predicting preeclampsia: a secondary analysis of data from the inspire trial","volume":"22","author":"Kifle","year":"2022","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.jri.2024.104282_bib61","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1186\/s12884-022-04817-6","article-title":"The prognostic utility of soluble fms-like tyrosine kinase-1 (sflt-1) and placental growth factor (pigf) biomarkers for predicting preeclampsia: a secondary analysis of data from the inspire trial","volume":"22","author":"Kifle","year":"2022","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.jri.2024.104282_bib62","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1053\/plac.1999.0496","article-title":"Surface expression of hla-c antigen by human extravillous trophoblast","volume":"21","author":"King","year":"2000","journal-title":"Placenta"},{"key":"10.1016\/j.jri.2024.104282_bib63","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.smim.2007.10.007","article-title":"Th17 cells: effector t cells with inflammatory properties","volume":"19","author":"Korn","year":"2007","journal-title":"Semin Immunol."},{"key":"10.1016\/j.jri.2024.104282_bib64","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/humupd\/dmq007","article-title":"An immunological insight into the origins of pre-eclampsia","volume":"16","author":"Laresgoiti-Servitje","year":"2010","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.jri.2024.104282_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2012.06.047","article-title":"Systemic inflammatory stimulation by microparticles derived from hypoxic trophoblast as a model for inflammatory response in preeclampsia","volume":"207","author":"Lee","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"9","key":"10.1016\/j.jri.2024.104282_bib66","doi-asserted-by":"crossref","first-page":"6133","DOI":"10.1074\/jbc.M008496200","article-title":"A specific interferon (ifn)-stimulated response element of the distal hla-g promoter binds ifn-regulatory factor 1 and mediates enhancement of this nonclassical class i gene by ifn-beta","volume":"276","author":"Lefebvre","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jri.2024.104282_bib67","first-page":"1809","article-title":"Human cytotrophoblast differentiation\/invasion is abnormal in pre-eclampsia","volume":"151","author":"Lim","year":"1997","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jri.2024.104282_bib68","first-page":"1","article-title":"Unraveling the molecular mechanisms driving enhanced invasion capability of extravillous trophoblast cells: a comprehensive review","author":"Lin","year":"2024","journal-title":"J. Assist. Reprod. Genet."},{"key":"10.1016\/j.jri.2024.104282_bib69","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/AOG.0000000000000472","article-title":"Maternal morbidity associated with early-onset and late-onset preeclampsia","volume":"124","author":"Lisonkova","year":"2014","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jri.2024.104282_bib70","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/molehr\/gas041","article-title":"The maternal hla-g 1597deltac null mutation is associated with increased risk of pre-eclampsia and reduced hla-g expression during pregnancy in african-american women","volume":"19","author":"Loisel","year":"2013","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.jri.2024.104282_bib71","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3389\/fimmu.2014.00312","article-title":"Complement activation and regulation in preeclamptic placenta","volume":"5","author":"Lokki","year":"2014","journal-title":"Front Immunol."},{"key":"10.1016\/j.jri.2024.104282_bib72","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/j.molimm.2006.01.007","article-title":"Regulatory role of tryptophan degradation pathway in hla-g expression by human monocyte-derived dendritic cells","volume":"43","author":"Lopez","year":"2006","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jri.2024.104282_bib73","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/S0002-9440(10)63029-5","article-title":"Transforming growth factor-beta expression in human placenta and placental bed in third trimester normal pregnancy, preeclampsia, and fetal growth restriction","volume":"159","author":"Lyall","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jri.2024.104282_bib74","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.humimm.2022.07.004","article-title":"Expression level of immune checkpoint inhibitory factors in preeclampsia","volume":"83","author":"Madadi","year":"2022","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.jri.2024.104282_bib75","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000087912","article-title":"Immunology of preeclampsia","volume":"89","author":"Matthiesen","year":"2005","journal-title":"Chem. Immunol. Allergy"},{"key":"10.1016\/j.jri.2024.104282_bib76","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sflt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.jri.2024.104282_bib77","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3389\/fendo.2020.00655","article-title":"Mechanisms of endothelial dysfunction in pre-eclampsia and gestational diabetes mellitus: windows into future cardiometabolic health?","volume":"11","author":"Mcelwain","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.jri.2024.104282_bib78","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.placenta.2009.11.011","article-title":"Feto-maternal interactions in pregnancies: Placental microparticles activate peripheral blood monocytes","volume":"31","author":"Messerli","year":"2010","journal-title":"Placenta"},{"key":"10.1016\/j.jri.2024.104282_bib79","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.rbmo.2016.08.019","article-title":"Variation of maternal kir and fetal hla-c genes in reproductive failure: Too early for clinical intervention","volume":"33","author":"Moffett","year":"2016","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.jri.2024.104282_bib80","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nri886","article-title":"Natural killer cells and pregnancy","volume":"2","author":"Moffett-King","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jri.2024.104282_bib81","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jri.2015.05.007","article-title":"Increased circulating interleukin-17 levels in preeclampsia","volume":"112","author":"Molvarec","year":"2015","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2024.104282_bib82","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jri.2015.05.007","article-title":"Increased circulating interleukin-17 levels in preeclampsia","volume":"112","author":"Molvarec","year":"2015","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2024.104282_bib83","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.1210\/en.2004-0533","article-title":"Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia","volume":"145","author":"Nagamatsu","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.jri.2024.104282_bib84","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1161\/HYPERTENSIONAHA.120.15870","article-title":"Preeclamptic women have decreased circulating il-10 (interleukin-10) values at the time of preeclampsia diagnosis: systematic review and meta-analysis","volume":"76","author":"Nath","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.jri.2024.104282_bib85","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nri3084","article-title":"Towards a systems understanding of mhc class i and mhc class ii antigen presentation","volume":"11","author":"Neefjes","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jri.2024.104282_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogoh.2020.101975","article-title":"Preeclampsia: pathophysiology and management","volume":"50","author":"Nirupama","year":"2021","journal-title":"J. Gynecol. Obstet. Hum. Reprod."},{"key":"10.1016\/j.jri.2024.104282_bib87","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1007\/s43032-022-01110-x","article-title":"The role of interferon (ifn)-\u03b3 in extravillous trophoblast cell (evt) invasion and preeclampsia progression","volume":"30","author":"Nurzadeh","year":"2023","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.jri.2024.104282_bib88","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.3389\/fimmu.2019.02730","article-title":"The dual role of hla-c in tolerance and immunity at the maternal-fetal interface","volume":"10","author":"Pap\u00fachov\u00e1","year":"2019","journal-title":"Front Immunol."},{"key":"10.1016\/j.jri.2024.104282_bib89","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nri1570","article-title":"Mhc class i molecules and kirs in human history, health and survival","volume":"5","author":"Parham","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jri.2024.104282_bib90","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1161\/HYPERTENSIONAHA.119.13997","article-title":"Angiogenic marker prognostic models in pregnant women with hypertension","volume":"75","author":"Perry","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.jri.2024.104282_bib91","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.3389\/fimmu.2019.03098","article-title":"Dysregulation of complement activation and placental dysfunction: a potential target to treat preeclampsia?","volume":"10","author":"Pierik","year":"2019","journal-title":"Front Immunol."},{"key":"10.1016\/j.jri.2024.104282_bib92","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1007\/s43032-022-01059-x","article-title":"Preeclampsia-derived exosomes imbalance the activity of th17 and treg in pbmcs from healthy pregnant women","volume":"30","author":"Pourakbari","year":"2023","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.jri.2024.104282_bib93","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12958-022-01003-3","article-title":"Diagnostic biomolecules and combination therapy for pre-eclampsia","volume":"20","author":"Qi","year":"2022","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.jri.2024.104282_bib94","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3889\/oamjms.2023.11644","article-title":"Profile tumor necrosis factor alpha and procalcitonin in preeclampsia and preeclampsia with sepsis","volume":"11","author":"Rahardjo","year":"2023","journal-title":"Open Access Maced. J. Med. Sci."},{"key":"10.1016\/j.jri.2024.104282_bib95","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.313276","article-title":"Preeclampsia: pathophysiology, challenges, and perspectives","volume":"124","author":"Rana","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.jri.2024.104282_bib96","doi-asserted-by":"crossref","first-page":"S1019","DOI":"10.1016\/j.ajog.2020.10.022","article-title":"Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders","volume":"226","author":"Rana","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jri.2024.104282_bib97","series-title":"Chesley's hypertensive disorders in pregnancy","first-page":"131","article-title":"The immunology of preeclampsia","author":"Redman","year":"2022"},{"key":"10.1016\/j.jri.2024.104282_bib98","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1600-0897.2010.00831.x","article-title":"Immunology of pre-eclampsia","volume":"63","author":"Redman","year":"2010","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2024.104282_bib99","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0002-9378(99)70325-X","article-title":"Expression of the placental cytokines tumor necrosis factor alpha, interleukin 1beta, and interleukin 10 is increased in preeclampsia","volume":"181","author":"Rinehart","year":"1999","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jri.2024.104282_bib100","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1161\/01.HYP.0000188408.49896.c5","article-title":"Preeclampsia: recent insights","volume":"46","author":"Roberts","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.jri.2024.104282_bib101","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3389\/fimmu.2019.00478","article-title":"Therapeutic potential of regulatory t cells in preeclampsia\u2014opportunities and challenges","volume":"10","author":"Robertson","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jri.2024.104282_bib102","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013288","article-title":"Abnormalities in oxygen sensing define early and late onset preeclampsia as distinct pathologies","volume":"5","author":"Rolfo","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jri.2024.104282_bib103","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.placenta.2022.02.017","article-title":"Comparison of circulating total sflt-1 to placental-specific sflt-1 e15a in women with suspected preeclampsia","volume":"120","author":"Rowson","year":"2022","journal-title":"Placenta"},{"key":"10.1016\/j.jri.2024.104282_bib104","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0165-0378(03)00045-7","article-title":"Th1\/th2 balance in preeclampsia","volume":"59","author":"Saito","year":"2003","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2024.104282_bib105","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.4049\/jimmunol.1501229","article-title":"Tissue-specific education of decidual nk cells","volume":"195","author":"Sharkey","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.jri.2024.104282_bib106","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1152\/physiolgenomics.00106.2016","article-title":"Hla gene expression is altered in whole blood and placenta from women who later developed preeclampsia","volume":"49","author":"Small","year":"2017","journal-title":"Physiol. Genom."},{"key":"10.1016\/j.jri.2024.104282_bib107","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1152\/physiolgenomics.00106.2016","article-title":"Hla gene expression is altered in whole blood and placenta from women who later developed preeclampsia","volume":"49","author":"Small","year":"2017","journal-title":"Physiol. Genom."},{"key":"10.1016\/j.jri.2024.104282_bib108","first-page":"95","article-title":"Angiotensin type 2 receptor gene polymorphisms and susceptibility to preeclampsia","volume":"19","author":"Soltani-Zangbar","year":"2018","journal-title":"J. Reprod. Infertil."},{"key":"10.1016\/j.jri.2024.104282_bib109","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020245","article-title":"The immunomodulatory role of syncytiotrophoblast microvesicles","volume":"6","author":"Southcombe","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.jri.2024.104282_bib110","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2023-003324","article-title":"Effect of the interaction between advanced maternal age and pre-pregnancy bmi on pre-eclampsia and gdm in central china","volume":"11","author":"Sun","year":"2023","journal-title":"BMJ Open Diabetes Res. Care"},{"issue":"1","key":"10.1016\/j.jri.2024.104282_bib111","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12884-021-04152-2","article-title":"Fetal growth restriction as the initial finding of preeclampsia is a clinical predictor of maternal and neonatal prognoses: a single-center retrospective study","volume":"21","author":"Takahashi","year":"2021","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.jri.2024.104282_bib112","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02729","article-title":"Fetal-maternal immune interactions in pregnancy","volume":"10","author":"Than","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jri.2024.104282_bib113","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1600-0897.2010.00810.x","article-title":"Interleukin-10: a multi-faceted agent of pregnancy","volume":"63","author":"Thaxton","year":"2010","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2024.104282_bib114","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/biolre\/iox009","article-title":"Nlrp2 is a suppressor of nf-\u03bab signaling and hla-c expression in human trophoblasts","volume":"96","author":"Tilburgs","year":"2017","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.jri.2024.104282_bib115","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev-genom-091212-153455","article-title":"Major histocompatibility complex genomics and human disease","volume":"14","author":"Trowsdale","year":"2013","journal-title":"Annu Rev. Genom. Hum. Genet"},{"key":"10.1016\/j.jri.2024.104282_bib116","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1401738","article-title":"Cd4+ t cell heterogeneity in gestational age and preeclampsia using single-cell rna sequencing","volume":"15","author":"Tsuda","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jri.2024.104282_bib117","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S1074-7613(00)80394-5","article-title":"Human diversity in killer cell inhibitory receptor genes","volume":"7","author":"Uhrberg","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.jri.2024.104282_bib118","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1186\/s12887-022-03542-5","article-title":"A review of infant growth and psychomotor developmental outcomes after intrauterine exposure to preeclampsia","volume":"22","author":"Vakil","year":"2022","journal-title":"BMC Pediatr."},{"issue":"1","key":"10.1016\/j.jri.2024.104282_bib119","first-page":"10","article-title":"Angiogenic factors and the risk of preeclampsia: a systematic review and meta-analysis","volume":"17","author":"Veisani","year":"2019","journal-title":"Int J. Reprod. Biomed."},{"issue":"1","key":"10.1016\/j.jri.2024.104282_bib120","article-title":"Angiogenic factors and the risk of preeclampsia: a systematic review and meta-analysis","volume":"17","author":"Veisani","year":"2019","journal-title":"Int. J. Reprod. Biomed."},{"key":"10.1016\/j.jri.2024.104282_bib121","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/HYPERTENSIONAHA.113.01787","article-title":"New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1\/placental growth factor ratio as a diagnostic test for preeclampsia","volume":"63","author":"Verlohren","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.jri.2024.104282_bib122","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/HYPERTENSIONAHA.113.01787","article-title":"New gestational phase\u2013specific cutoff values for the use of the soluble fms-like tyrosine kinase-1\/placental growth factor ratio as a diagnostic test for preeclampsia","volume":"63","author":"Verlohren","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.jri.2024.104282_bib123","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10456-018-9637-2","article-title":"Angiogenic capacity in pre-eclampsia and uncomplicated pregnancy estimated by assay of angiogenic proteins and an in vitro vasculogenesis\/angiogenesis test","volume":"22","author":"Virtanen","year":"2019","journal-title":"Angiogenesis"},{"key":"10.1016\/j.jri.2024.104282_bib124","doi-asserted-by":"crossref","first-page":"6985","DOI":"10.3390\/ijms22136985","article-title":"The road to low-dose aspirin therapy for the prevention of preeclampsia began with the placenta","volume":"22","author":"Walsh","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jri.2024.104282_bib125","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3390\/biology12030402","article-title":"Innate and adaptive immune systems in physiological and pathological pregnancy","volume":"12","author":"Weng","year":"2023","journal-title":"Biology"},{"key":"10.1016\/j.jri.2024.104282_bib126","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/01.AOG.0000249609.04831.7c","article-title":"Mapping the theories of preeclampsia and the role of angiogenic factors: A systematic review","volume":"109","author":"Widmer","year":"2007","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jri.2024.104282_bib127","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/brain\/awg017","article-title":"The non-classical mhc molecule hla-g protects human muscle cells from immune-mediated lysis: Implications for myoblast transplantation and gene therapy","volume":"126","author":"Wiendl","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.jri.2024.104282_bib128","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/HYPERTENSIONAHA.107.091322","article-title":"Potential roles of angiotensin receptor-activating autoantibody in the pathophysiology of preeclampsia","volume":"50","author":"Xia","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.jri.2024.104282_bib129","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.4049\/jimmunol.179.6.3391","article-title":"Angiotensin receptors, auto-immunity and preeclampsia","volume":"179","author":"Xia","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jri.2024.104282_bib130","first-page":"1612","article-title":"Contribution of natural killer cells to inhibition of angiogenesis by interleukin-12","volume":"93","author":"Yao","year":"1999","journal-title":"Blood, J. Am. Soc. Hematol."},{"key":"10.1016\/j.jri.2024.104282_bib131","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/humrep\/dei305","article-title":"Progesterone enhances hla-g gene expression in jeg-3 choriocarcinoma cells and human cytotrophoblasts in vitro","volume":"21","author":"Yie","year":"2006","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.jri.2024.104282_bib132","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1080\/08820139.2021.1909061","article-title":"Fetomaternal immune tolerance: crucial mechanisms of tolerance for successful pregnancy in humans","volume":"51","author":"Yousefzadeh","year":"2022","journal-title":"Immunol. Investig."},{"key":"10.1016\/j.jri.2024.104282_bib133","doi-asserted-by":"crossref","first-page":"10183","DOI":"10.1007\/s11033-022-07887-z","article-title":"Evaluation of cd39, cd73, hif-1\u03b1, and their related mirnas expression in decidua of preeclampsia cases compared to healthy pregnant women","volume":"49","author":"Yousefzadeh","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.jri.2024.104282_bib134","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/pd.2848","article-title":"Uterine artery doppler and biochemical markers (papp-a, plgf, sflt-1, p-selectin, ngal) at 11+ 0 to 13+ 6 weeks in the prediction of late (> 34 weeks) pre-eclampsia","volume":"31","author":"Youssef","year":"2011","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.jri.2024.104282_bib135","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/pd.2848","article-title":"Uterine artery doppler and biochemical markers (papp-a, pigf, sflt-1, p-selectin, ngal) at 11\u2009+\u20090 to 13\u2009+\u20096 weeks in the prediction of late (> 34 weeks) pre-eclampsia","volume":"31","author":"Youssef","year":"2011","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.jri.2024.104282_bib136","series-title":"Seminars in immunopathology","first-page":"123","article-title":"Unk cells: their role in tissue re-modelling and preeclampsia","author":"Zhang","year":"2007"},{"key":"10.1016\/j.jri.2024.104282_bib137","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/nm.1856","article-title":"Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice","volume":"14","author":"Zhou","year":"2008","journal-title":"Nat. Med"},{"key":"10.1016\/j.jri.2024.104282_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2021.103317","article-title":"A new approach to the preeclampsia puzzle; microrna-326 in cd4+ lymphocytes might be as a potential suspect","volume":"145","author":"Zolfaghari","year":"2021","journal-title":"J. Reprod. Immunol."}],"container-title":["Journal of Reproductive Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165037824000913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165037824000913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T16:31:04Z","timestamp":1721665864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165037824000913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":138,"alternative-id":["S0165037824000913"],"URL":"https:\/\/doi.org\/10.1016\/j.jri.2024.104282","relation":{},"ISSN":["0165-0378"],"issn-type":[{"value":"0165-0378","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunological mechanisms in preeclampsia: A narrative review","name":"articletitle","label":"Article Title"},{"value":"Journal of Reproductive Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jri.2024.104282","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104282"}}